188 related articles for article (PubMed ID: 33843452)
1. Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein.
Hodge CD; Rosenberg DJ; Grob P; Wilamowski M; Joachimiak A; Hura GL; Hammel M
MAbs; 2021; 13(1):1905978. PubMed ID: 33843452
[TBL] [Abstract][Full Text] [Related]
2. Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein.
Hodge CD; Rosenberg DJ; Wilamowski M; Joachimiak A; Hura GL; Hammel M
bioRxiv; 2021 Jan; ():. PubMed ID: 33469584
[TBL] [Abstract][Full Text] [Related]
3. Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes.
Lee JH; Jung Y; Lee SK; Kim J; Lee CS; Kim S; Lee JS; Kim NH; Kim HG
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215848
[TBL] [Abstract][Full Text] [Related]
4. Characterization and application of a series of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein.
Zhou L; Mo C; Yang Y; Zhou Z; You A; Fan Y; Liu W; Li X; Zhou R; Tian X
J Med Virol; 2023 Jan; 95(1):e28225. PubMed ID: 36238992
[TBL] [Abstract][Full Text] [Related]
5. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19.
Lu RM; Ko SH; Chen WY; Chang YL; Lin HT; Wu HC
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830291
[TBL] [Abstract][Full Text] [Related]
7. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
[TBL] [Abstract][Full Text] [Related]
8. Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests.
Yamaoka Y; Miyakawa K; Jeremiah SS; Funabashi R; Okudela K; Kikuchi S; Katada J; Wada A; Takei T; Nishi M; Shimizu K; Ozawa H; Usuku S; Kawakami C; Tanaka N; Morita T; Hayashi H; Mitsui H; Suzuki K; Aizawa D; Yoshimura Y; Miyazaki T; Yamazaki E; Suzuki T; Kimura H; Shimizu H; Okabe N; Hasegawa H; Ryo A
Cell Rep Med; 2021 Jun; 2(6):100311. PubMed ID: 34027498
[TBL] [Abstract][Full Text] [Related]
9. [Development and application of triple antibodies-based sandwich ELISA for detecting nucleocapsid protein of SARS-associated coronavirus].
Qiu LW; Tang HW; Wang YD; Liao JE; Hao W; Wen K; He XM; Che XY
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):277-81. PubMed ID: 15941537
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses.
Wen Y; Guo W; Min Y; Zhong K; Zhang X; Xing X; Tong Y; Pan Y; Hong W; Cai W; Yu L
Front Immunol; 2023; 14():1093709. PubMed ID: 36798118
[TBL] [Abstract][Full Text] [Related]
11. Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron.
Zhou B; Cheng L; Song S; Guo H; Shen S; Wang H; Ge X; Liu L; Ju B; Zhang Z
Virol J; 2022 May; 19(1):96. PubMed ID: 35643510
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of a novel monoclonal antibody specific to severe acute respiratory syndrome-coronavirus nucleocapsid protein.
Shin GC; Chung YS; Kim IS; Cho HW; Kang C
Virus Res; 2006 Dec; 122(1-2):109-18. PubMed ID: 16942813
[TBL] [Abstract][Full Text] [Related]
13. Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA.
He Q; Du Q; Lau S; Manopo I; Lu L; Chan SW; Fenner BJ; Kwang J
J Virol Methods; 2005 Jul; 127(1):46-53. PubMed ID: 15893565
[TBL] [Abstract][Full Text] [Related]
14. High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection.
Fujisawa M; Adachi Y; Onodera T; Shiwa-Sudo N; Iwata-Yoshikawa N; Nagata N; Suzuki T; Takeoka S; Takahashi Y
Biochem Biophys Res Commun; 2023 Sep; 673():114-120. PubMed ID: 37379800
[TBL] [Abstract][Full Text] [Related]
15. Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus.
Shang B; Wang XY; Yuan JW; Vabret A; Wu XD; Yang RF; Tian L; Ji YY; Deubel V; Sun B
Biochem Biophys Res Commun; 2005 Oct; 336(1):110-7. PubMed ID: 16112641
[TBL] [Abstract][Full Text] [Related]
16. Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together.
Zhang L; Poorbaugh J; Dougan M; Chen P; Gottlieb RL; Huhn G; Beasley S; Daniels M; Ngoc Vy Trinh T; Crisp M; Freitas JJ; Vaillancourt P; Patel DR; Nirula A; Kallewaard NL; Higgs RE; Benschop RJ
Front Immunol; 2021; 12():790469. PubMed ID: 34956222
[TBL] [Abstract][Full Text] [Related]
17. Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies.
Kim J; Kim D; Baek K; Kim M; Kang BM; Maharjan S; Park S; Choi JK; Kim S; Kim YK; Park MS; Lee Y; Kwon HJ
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680068
[TBL] [Abstract][Full Text] [Related]
18. Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Dussupt V; Sankhala RS; Mendez-Rivera L; Townsley SM; Schmidt F; Wieczorek L; Lal KG; Donofrio GC; Tran U; Jackson ND; Zaky WI; Zemil M; Tritsch SR; Chen WH; Martinez EJ; Ahmed A; Choe M; Chang WC; Hajduczki A; Jian N; Peterson CE; Rees PA; Rutkowska M; Slike BM; Selverian CN; Swafford I; Teng IT; Thomas PV; Zhou T; Smith CJ; Currier JR; Kwong PD; Rolland M; Davidson E; Doranz BJ; Mores CN; Hatziioannou T; Reiley WW; Bieniasz PD; Paquin-Proulx D; Gromowski GD; Polonis VR; Michael NL; Modjarrad K; Joyce MG; Krebs SJ
Nat Immunol; 2021 Dec; 22(12):1503-1514. PubMed ID: 34716452
[TBL] [Abstract][Full Text] [Related]
19. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
20. A luciferase immunosorbent assay for quantitative detection of IgG antibodies against SARS-CoV-2 nucleoprotein.
Liang Y; Yan H; Huang L; Zhao J; Wang H; Kang M; Wan Z; Shui J; Tang S
J Virol Methods; 2021 Jun; 292():114141. PubMed ID: 33753172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
